All lobbying filings

AVIVA STRATEGIES (FKA MGB CONSULTING)

AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q3 report for ENDEAVOR BIOMEDICINES on October 15, 2025, reporting $51,000 in lobbying income.

Lobbying for ENDEAVOR BIOMEDICINES · Biotechnology & therapeutics

All filings by AVIVA STRATEGIES (FKA MGB CONSULTING) · Everything ENDEAVOR BIOMEDICINES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 15, 2025

Income

$51,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

RESULT Act FDA Modernization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem